Delayed gastric emptying by Helicobacter pylori lipopolysaccharide in conscious rats. 1998

T Okumura, and E Shoji, and N Takahashi, and H Wakebe, and K Imagawa, and M Kikuchi, and Y Kohgo
Third Department of Internal Medicine, Asahikawa Medical College, Hokkaido, Japan.

The present study was carried out to investigate the possibility that lipopolysaccharide deprived from Helicobacter pylori may alter gastric motility. To address the question, we examined the effect of H. pylori lipopolysaccharide on gastric emptying in conscious rats. Gastric emptying was evaluated by the phenol red method. Time-course and dose-related effects of intraperitoneal administration of H. pylori lipopolysaccharide were investigated. Intraperitoneal injection of H. pylori lipopolysaccharide significantly suppressed gastric emptying of a liquid meal in a dose-dependent manner. The inhibitory action of H. pylori lipopolysaccharide was observed 2, 4, 8, or 12 hr after the injection. These results suggest for the first time that H. pylori lipopolysaccharide may suppress gastric emptying in a long-lasting fashion. It is also suggested that H. pylori may influence gastric function through its cell wall structure named lipopolysaccharide.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008297 Male Males
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005746 Gastric Emptying The evacuation of food from the stomach into the duodenum. Emptying, Gastric,Emptyings, Gastric,Gastric Emptyings
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016480 Helicobacter pylori A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405). Campylobacter pylori,Campylobacter pylori subsp. pylori,Campylobacter pyloridis,Helicobacter nemestrinae
D016481 Helicobacter Infections Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease. Infections, Helicobacter,Helicobacter Infection,Infection, Helicobacter
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

T Okumura, and E Shoji, and N Takahashi, and H Wakebe, and K Imagawa, and M Kikuchi, and Y Kohgo
July 2021, Experimental and therapeutic medicine,
T Okumura, and E Shoji, and N Takahashi, and H Wakebe, and K Imagawa, and M Kikuchi, and Y Kohgo
July 1997, Biochemical and biophysical research communications,
T Okumura, and E Shoji, and N Takahashi, and H Wakebe, and K Imagawa, and M Kikuchi, and Y Kohgo
November 1995, European journal of nuclear medicine,
T Okumura, and E Shoji, and N Takahashi, and H Wakebe, and K Imagawa, and M Kikuchi, and Y Kohgo
January 1995, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie,
T Okumura, and E Shoji, and N Takahashi, and H Wakebe, and K Imagawa, and M Kikuchi, and Y Kohgo
May 2012, Hepato-gastroenterology,
T Okumura, and E Shoji, and N Takahashi, and H Wakebe, and K Imagawa, and M Kikuchi, and Y Kohgo
November 1999, The American journal of gastroenterology,
T Okumura, and E Shoji, and N Takahashi, and H Wakebe, and K Imagawa, and M Kikuchi, and Y Kohgo
November 1998, The American journal of gastroenterology,
T Okumura, and E Shoji, and N Takahashi, and H Wakebe, and K Imagawa, and M Kikuchi, and Y Kohgo
December 1995, Nuclear medicine communications,
T Okumura, and E Shoji, and N Takahashi, and H Wakebe, and K Imagawa, and M Kikuchi, and Y Kohgo
December 1993, Biochemistry and molecular biology international,
T Okumura, and E Shoji, and N Takahashi, and H Wakebe, and K Imagawa, and M Kikuchi, and Y Kohgo
March 1991, Biochemical and biophysical research communications,
Copied contents to your clipboard!